Recommended Conferences

Clinical Microbiology and Infectious Diseases

Miami, USA

Fungal Infections and Treatments

Miami, USA

Cancer-Treatment and Therapeutics

New York, USA
Related Subjects
 

Platelet-rich fibrin matrix (PRFM) for androgenetic alopecia

Author(s): Sclafani AP

Abstract

The objective of this study was to determine the effect of platelet-rich fibrin matrix (PRFM) treatment on androgenetic alopecia. Prospective cohort study of 15 (9 male and 6 female) subjects with androgenetic alopecia for at least 1 year who were treated with intradermal injections of autologous PRFM three times on a monthly basis. Hair density indices were measured in triplicate in the same area of the scalp before the treatment and 1, 2, 3 and 6 months after initial treatment. Hair density index (HDI) measurements were obtained and compared with pretreatment values for each subject. After a series of three intradermal PRFM injections, hair density indices increased significantly at 2 (47.4 ± 22.7%, p = 0.0031) and 3 (106.4 ± 56.9%, p = 0.0277, paired t-test) months after the initial treatment, and approached statistical significance at 6 months (75.1 ± 46.82%, p = 0.0606) after the initial treatment. Patients who achieved greater than 25% increase in HDI by 2 months after the initial treatment were more likely to have greater than 25% improvement at 6 months after the initial treatment (100 vs. 16.7%, p = 0.0476). Androgenetic alopecia affects a significant number of both men and women. A series of intradermal injections of autologous PRFM increased the HDI in patients with androgenetic alopecia at 2 and 3 months after initial treatment; this improvement approached statistical significance at 6 months after initiating treatment. Autologous PRFM injections may be a valuable treatment for androgenetic alopecia, particularly in cases with mild hair loss. The level of evidence is level 2.

Similar Articles

Clinical utility and validity of minoxidil response testing in androgenetic alopecia

Author(s): Goren A, Shapiro J, Roberts J, McCoy J, Desai N, et al.

Androgenetic alopecia: an update

Author(s): Kaliyadan F, Nambiar A, Vijayaraghavan S

Effectiveness of Platelet-Rich Plasma for Androgenetic Alopecia: A Review of the Literature

Author(s): Cervantes J, Perper M, Wong L, Eber A, Villasante A, et al.

Hair follicle growth by stromal vascular fraction-enhanced adipose transplantation in baldness

Author(s): Perez-Meza D, Ziering C, Sforza M, Krishnan G, Ball E, et al.

Classification of Male-pattern Hair Loss

Author(s): Wirya CT, Wu W, Wu K

Adipocyte lineage cells contribute to the skin stem cell niche to drive hair cycling

Author(s): Festa E, Fretz J, Berry R, Schmidt B, Rodeheffer M, et al.

The Effect of Plasma Rich in Growth Factors on Pattern Hair Loss: A Pilot Study

Author(s): Anitua E, Pino A, Martinez N, Orive G, Berridi D

The Effect of Platelet-Rich Plasma in Hair Regrowth: A Randomized Placebo-Controlled Trial

Author(s): Gentile P, Garcovich S, Bielli A, Scioli MG, Orlandi A, et al.

Study of platelet-rich plasma injections in the treatment of androgenetic alopecia through an one-year period

Author(s): Gkini MA, Kouskoukis AE, Tripsianis G, Rigopoulos D, Kouskoukis K

Stem cell therapy as a novel therapeutic intervention for resistant cases of alopecia areata and androgenetic alopecia

Author(s): Ibrahim ZA, Elmaadawi IH, Mohamed BM, Abdou SM, El Attar YA, et al.